Related references
Note: Only part of the references are listed.Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors
Cuneyt Turkes et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies
Sukru Beydemir et al.
DRUG AND CHEMICAL TOXICOLOGY (2021)
Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes
Cuneyt Turkes et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors
Suleyman Akocak et al.
CHEMISTRY & BIODIVERSITY (2021)
Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors
Sercan Askin et al.
BIOORGANIC CHEMISTRY (2021)
A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity
Belgin Sever et al.
OPEN CHEMISTRY (2021)
Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors
Muharrem Kalayci et al.
ARCHIV DER PHARMAZIE (2021)
Inhibition of Human Serum Paraoxonase-I with Antimycotic Drugs: In Vitro and In Silico Studies
Cuneyt Turkes et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2020)
Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies
Mesut Isik et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I
Yeliz Demir et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors
Qendresa Istrefi et al.
ARCHIV DER PHARMAZIE (2020)
Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives
Mesut Isik et al.
ARCHIV DER PHARMAZIE (2020)
Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, ?-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs
Nebih Lolak et al.
BIOORGANIC CHEMISTRY (2020)
Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors
Belgin Sever et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Mannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: Synthesis, spectroscopy and in vitro/in silico biological studies
Ahmet Kilic et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2020)
Molecular docking and investigation of 4-(benzylideneamino)- and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors
Mesut Isik et al.
CHEMICAL PAPERS (2020)
Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases
Mustafa Durgun et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs
Cuneyt Turkes
PROTEIN AND PEPTIDE LETTERS (2019)
A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors
Cuneyt Turkes
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors
Cuneyt Turkes et al.
BIOORGANIC CHEMISTRY (2019)
In Vitro and In Silico Studies on the Toxic Effects of Antibacterial Drugs as Human Serum Paraoxonase 1 Inhibitor
Cuneyt Turkes et al.
CHEMISTRYSELECT (2019)
Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies
Yaqian Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
New Isoindole-1,3-dione Substituted Sulfonamides as Potent Inhibitors of Carbonic Anhydrase and Acetylcholinesterase: Design, Synthesis, and Biological Evaluation
Saliha Gundogdu et al.
CHEMISTRYSELECT (2019)
The role of Various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts
Hana Polachek et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1
Elisa Herraez et al.
ONCOTARGET (2017)
Global marine pollutants inhibit P-glycoprotein: Environmental levels, inhibitory effects, and cocrystal structure
Sascha C. T. Nicklisch et al.
SCIENCE ADVANCES (2016)
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Hisham Qosa et al.
BRAIN RESEARCH (2015)
Why are second-generation H1-antihistamines minimally sedating?
Yawen Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Antipyretic effect of dexamethasone in community-acquired pneumonia
Stefan M. T. Vestjens et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Towards understanding promiscuity in multidrug efflux pumps
Kelvin Wong et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption
Yoshihisa Shitara et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Transporter Studies in Drug Development: Experience to Date and Follow-Up on Decision Trees From the International Transporter Consortium
D. Tweedie et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Taxanes: Old drugs, new oral formulations
Rajni A. Jibodh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study
Gary N. Y. Chan et al.
JOURNAL OF NEUROCHEMISTRY (2013)
The SLCO (former SLC21) superfamily of transporters
Bruno Hagenbuch et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Role of ABC transporters in lipid transport and human disease
Elizabeth J. Tarling et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Drug Transporters in Drug Efficacy and Toxicity
M. K. DeGorter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies
Megan Roth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Corticosteroids for severe sepsis: an evidence-based guide for physicians
Djillali Annane
ANNALS OF INTENSIVE CARE (2011)
Carrier-mediated uptake of Levofloxacin by BeWo cells, a human trophoblast cell line
Hana Polachek et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines
Kamila Ambroziak et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Effect of Piperine, a Major Component of Black Pepper, on the Intestinal Absorption of Fexofenadine and Its Implication on Food-Drug Interaction
Ming-Ji Jin et al.
JOURNAL OF FOOD SCIENCE (2010)
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier
Vishal S. Narang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia
Mary Bebawy et al.
BIOESSAYS (2008)
Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1
Tomohiro Nabekura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein
Hao-Jie Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity
Jun Moriguchi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats
Yasuyoshi Ishwata et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly
Stanislav Micuda et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Identification of influx transporter for the quinolone antibacterial agent levofloxacin
Tomoji Maeda et al.
MOLECULAR PHARMACEUTICS (2007)
Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats
R. J. Dinis-Oliveira et al.
TOXICOLOGY (2006)
New light on multidrug binding by an ATP-binding-cassette transporter
RA Shilling et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers
M Kageyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse
S Vautier et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier
H Bronger et al.
CANCER RESEARCH (2005)
Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM
I González-Alvarez et al.
XENOBIOTICA (2005)
Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function
PV Dicpinigaitis et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin
J Zong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Inhibition by fluoroquinolones of K+ currents in rat dissociated hippocampal neurons
LR Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Drug-drug interaction mediated by inhibition and induction of P-glycoprotein
JH Lin
ADVANCED DRUG DELIVERY REVIEWS (2003)
Levofloxacin - A review of its use in the treatment of bacterial infections in the United States
KF Croom et al.
DRUGS (2003)
Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy
T Shimada et al.
TRANSPLANTATION (2002)
Tissue distribution and chemical induction of multiple drug resistance genes in rats
JM Brady et al.
DRUG METABOLISM AND DISPOSITION (2002)
Comparison of side effects of levofloxacin versus other fluoroquinolones
C Carbon
CHEMOTHERAPY (2001)
Fexofenadine - A review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria
K Simpson et al.
DRUGS (2000)
Share Paper
